Hassanein Waleed H 4
4 · TransMedics Group, Inc. · Filed Aug 8, 2025
Insider Transaction Report
Form 4
Hassanein Waleed H
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2025-08-07$116.08/sh+6,617$768,101→ 484,376 total(indirect: By Trust) - Purchase
Common Stock
2025-08-06$118.68/sh+8,400$996,912→ 477,759 total(indirect: By Trust) - Purchase
Common Stock
2025-08-07$116.85/sh+1,858$217,107→ 486,234 total(indirect: By Trust)
Holdings
- 121,424
Common Stock
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $118.50 to $118.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $115.60 to $116.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $116.62 to $117.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.